Literature DB >> 10072525

Role of a STAT binding site in the regulation of the human perforin promoter.

C R Yu1, J R Ortaldo, R E Curiel, H A Young, S K Anderson, P Gosselin.   

Abstract

The pore-forming protein perforin is preferentially expressed in NK and cytotoxic T cells. To investigate the molecular regulation of human perforin gene transcription, the activity of the human perforin promoter was analyzed in human NK and T cell lines using various promoter fragments linked to a luciferase reporter gene. A core promoter was identified within 55 bp upstream of the transcription start site. This promoter region contains a guanine/cytosine box and has basal activity in YT, Kit225-k6, and Jurkat cells. A strong enhancer activity was identified between positions -1136 and -1076, a region that includes a STAT-like element. This enhancer region was active in YT cells, which have constitutive perforin expression and activated STAT3 protein, but not in Kit225-k6 or Jurkat cells, which do not have constitutive perforin expression. Mutation of the STAT binding site resulted in a dramatic down-regulation of promoter activity. Electrophoretic mobility shift assays, using a probe containing the STAT element of the perforin promoter, indicated that this element can bind STAT3 from YT cells. Moreover, the STAT element was shown to bind STAT5a/b induced by IL-2 as well as STAT1alpha induced by IL-6 in human NK cells. Together, these results suggest that STAT proteins play a key role in perforin gene transcription and provide a model by which cytokines can regulate perforin gene expression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10072525

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

Review 1.  The transcriptional control of the perforin locus.

Authors:  Matthew E Pipkin; Anjana Rao; Mathias G Lichtenheld
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

2.  A haplotype of CYP2C9 associated with warfarin sensitivity in mechanical heart valve replacement patients.

Authors:  Su-Jun Lee; Yin Jin Jang; Eun-Young Cha; Ho-Sook Kim; Sang Seop Lee; Jae-Gook Shin
Journal:  Br J Clin Pharmacol       Date:  2010-08       Impact factor: 4.335

3.  STAT5 is critical to maintain effector CD8+ T cell responses.

Authors:  Pulak Tripathi; Sema Kurtulus; Sara Wojciechowski; Allyson Sholl; Kasper Hoebe; Suzanne C Morris; Fred D Finkelman; H Leighton Grimes; David A Hildeman
Journal:  J Immunol       Date:  2010-07-19       Impact factor: 5.422

4.  HLA-G dimer targets Granzyme B pathway to prolong human renal allograft survival.

Authors:  Ashwin Ajith; Vera Portik-Dobos; Anh Thu Nguyen-Lefebvre; Christine Callaway; Daniel D Horuzsko; Rajan Kapoor; Carlos Zayas; Katsumi Maenaka; Laura L Mulloy; Anatolij Horuzsko
Journal:  FASEB J       Date:  2019-01-08       Impact factor: 5.191

5.  Biallelic mutations in IRF8 impair human NK cell maturation and function.

Authors:  Emily M Mace; Venetia Bigley; Justin T Gunesch; Ivan K Chinn; Laura S Angelo; Matthew A Care; Sheetal Maisuria; Michael D Keller; Sumihito Togi; Levi B Watkin; David F LaRosa; Shalini N Jhangiani; Donna M Muzny; Asbjørg Stray-Pedersen; Zeynep Coban Akdemir; Jansen B Smith; Mayra Hernández-Sanabria; Duy T Le; Graham D Hogg; Tram N Cao; Aharon G Freud; Eva P Szymanski; Sinisa Savic; Matthew Collin; Andrew J Cant; Richard A Gibbs; Steven M Holland; Michael A Caligiuri; Keiko Ozato; Silke Paust; Gina M Doody; James R Lupski; Jordan S Orange
Journal:  J Clin Invest       Date:  2016-11-28       Impact factor: 14.808

6.  Molecular mechanisms influencing NK cell development: implications for NK cell malignancies.

Authors:  Sally A Mujaj; Michelle M Spanevello; Maher K Gandhi; Jamie P Nourse
Journal:  Am J Blood Res       Date:  2011-05-22

7.  Differential effects of IL-21 and IL-15 on perforin expression, lysosomal degranulation, and proliferation in CD8 T cells of patients with human immunodeficiency virus-1 (HIV).

Authors:  Lesley White; Subramaniam Krishnan; Natasa Strbo; Huanliang Liu; Michael A Kolber; Mathias G Lichtenheld; Rajendra N Pahwa; Savita Pahwa
Journal:  Blood       Date:  2006-12-27       Impact factor: 22.113

8.  IL-21 augments natural killer effector functions in chronically HIV-infected individuals.

Authors:  Natasa Strbo; Lesley de Armas; Huanliang Liu; Michael A Kolber; Mathias Lichtenheld; Savita Pahwa
Journal:  AIDS       Date:  2008-08-20       Impact factor: 4.177

9.  Ruxolitinib partially reverses functional natural killer cell deficiency in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations.

Authors:  Alexander Vargas-Hernández; Emily M Mace; Ofer Zimmerman; Christa S Zerbe; Alexandra F Freeman; Sergio Rosenzweig; Jennifer W Leiding; Troy Torgerson; Matthew C Altman; Edith Schussler; Charlotte Cunningham-Rundles; Ivan K Chinn; Alexandre F Carisey; Imelda C Hanson; Nicholas L Rider; Steven M Holland; Jordan S Orange; Lisa R Forbes
Journal:  J Allergy Clin Immunol       Date:  2017-10-27       Impact factor: 10.793

10.  Evaluation of the Functional Capacity of NK Cells of Melanoma Patients in an In Vitro Model of NK Cell Contact with K562 and FemX Tumor Cell Lines.

Authors:  Gordana Konjevic; Ana Vuletic; Katarina Mirjacic Martinovic; Ana Krivokuca; Radmila Jankovic; Nada Babovic
Journal:  J Membr Biol       Date:  2017-09-08       Impact factor: 1.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.